Intelligent Bio Solutions...

NASDAQ: INBS · Real-Time Price · USD
1.46
-0.02 (-1.35%)
At close: Aug 15, 2025, 3:59 PM
1.52
4.11%
After-hours: Aug 15, 2025, 04:42 PM EDT

Intelligent Bio Solutions Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
728.87K 607.49K 872.29K 727.82K 823.8K 764.06K 796.09K 443.13K 457.06K 356.68K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
387.5K 384.38K 525.49K -87.73K 645.31K 564.82K 563.76K 393.56K 424.01K 112.64K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
341.37K 223.11K 346.8K 815.56K 178.49K 199.25K 232.33K 49.58K 33.05K 244.04K 311.32K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-2.55M -2.26M -2.73M -2.81M -2.95M -1.99M -2.53M -2.7M -2.56M -2.13M -1.22M -2.09M -1.34M -3.47M -1.44M -852.65K -3.14M -917K -663K
Interest Income
17.69K 21.94K 52.84K 70.53K 10.64K 3.51K 139.00 89.00 508.00 1.47K 7.61K 3.45K 2.9K 3.47K 4.6K 5.67K 7.63K 434.00 70.00
Pretax Income
-2.54M -2.25M -2.69M -2.79M -2.99M -1.98M -2.43M -2.67M -6.35M -427K -1.21M -2.09M -1.34M -3.46M -1.44M -850.23K -3.14M -1.99M -1.08M
Net Income
-2.54M -2.25M -2.69M -2.78M -2.98M -1.97M -2.42M -2.66M -6.34M -421K -1.21M -2.08M -1.34M -3.46M -1.43M -853K -3.13M -1.98M -1.07M
Selling & General & Admin
2.41M 1.81M 1.95M 2.67M 2.43M 1.71M 2.46M 2.43M 1.9M 2.25M 1.45M 1.46M 1.12M 1M 1.33M 1.15M 1.02M 858.54K 678.21K
Research & Development
n/a 506.94K 948.75K 750.09K 471.31K 348.45K 103.95K 127.06K 299.9K 1.19K 79.27K 692.61K 413.32K 2.64M 106.8K 1.31M 2.16M 341.82K 30.94K
Other Expenses
n/a 171.54K 174.29K 206.62K n/a n/a n/a 192.77K 281.31K 128.53K -311.32K -66.86K -192.5K -177.79K n/a -1.61M -34.29K -283K -50.56K
Operating Expenses
2.41M 2.49M 3.07M 3.63M 2.9M 2.19M 2.76M 2.75M 2.48M 2.38M 1.22M 2.09M 1.34M 3.47M 1.44M 852.65K 3.14M 917.33K 658.59K
Interest Expense
15K 13.5K 22.33K 54.55K 42.67K 32.47K 37.45K 59.58K 86.13K 76.77K 1.06K 2.65K 4.22K 675.00 n/a 2.36K 18.56K 986.86K 85.83K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a -1.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.79M 2.19M 3.6M 3.54M 3.86M 2.75M 3.32M 3.08M 2.9M 2.49M 1.22M 2.09M 1.34M 3.47M 1.44M 2.31M 3.17M 917.33K 718.42K
Income Tax Expense
n/a 7.33K n/a n/a -9.09K n/a n/a n/a -8.11K n/a -5.79K -10.03K -8.89K -3.83K -5.19K 2.77K -14.85K -6.42K -4.41K
Shares Outstanding (Basic)
5.77M 4.54M 3.18M 3.04M 2.08M 949.66K 1.95M 1M 1.11M 75.69K 1.24M 744.5K 744.5K 744.13K 700.31K 679.11K 589.79K 718.56K 719.16K
Shares Outstanding (Diluted)
5.77M 4.54M 3.81M 3.04M 2.08M 949.66K 1.95M 1M 1.11M 75.69K 744.5K 744.5K 744.5K 744.13K 700.31K 679.11K 589.79K 718.56K 719.16K
EPS (Basic)
-0.44 -0.5 -1.69 -1.75 -1.43 -2.07 -2.48 -2.53 -6.87 -0.56 -1.95 -3.35 -2.15 -5.58 -2.45 -1.62 -64.8 -5.52 -2.98
EPS (Diluted)
-0.44 -0.5 -0.7 -1.75 -1.43 -2.07 -12.48 -25.33 -68.67 -110.4 -19.2 -33.5 -2.15 -5.58 -2.45 -1.62 -64.8 -5.52 -2.98
EBITDA
-2.23M -1.94M -2.37M -2.45M -2.62M -1.65M -2.09M -2.44M -5.87M 47.85K 10.08K -2.09M -1.34M -3.46M -1.44M -847.87K -3.12M -1M -991K
EBIT
-2.54M -2.24M -2.67M -2.74M -2.94M -1.94M -2.4M -2.61M -6.27M -350K -1.21M -2.09M -1.34M -3.46M -1.44M -847.87K -3.12M -1M -991K
Depreciation & Amortization
301.98K 305.18K 303.11K 287.69K 327.52K 290.31K 307.56K 169.59K 398.99K 398.16K 1.22M 3.45K 2.9K 7.31K 6.67K 2.01K 31.26K -79.78K -324K